Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05301114 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Social Risk Factors and Discrimination in Cancer Survivorship

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 20, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Site contact updatedv7
  4. 2 versions Re-verified since Mar 13, 2023, no change to tracked fieldsv5-v6
  5. Eligibility criteria expanded, about 13 wordsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 25, 2022 to May 5, 2022
    v3
  2. Primary endpoints: 8 to 7v2 Show 4 more changesShow less
    • Start date: Apr 1, 2022 to Apr 25, 2022
    • Secondary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 2 words
    • Study description expanded, about 1 word
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to improve survivor health and well-being. This will be completed through three primary aims: 1) To ascertain workflow and map community resources needed to facilitate social risk factor screening and referral for breast and prostate cancer survivors in Washington, District of Columbia. 2) To determine impact of Community Health Worker (CHW) support on Black breast and prostate cancer survivor health and wellbeing as measured through quality of life (QOL) and social connection. 3) To determine impact of anti-racism training for staff and clinicians at three cancer centers on patient-reported discrimination.
Trial Details
NCT Number NCT05301114
Lead Sponsor Medstar Health Research Institute
Collaborators: George Washington University, Howard University, Georgetown University
Conditions
(from sponsor)		 Social Determinants of Health, Breast Cancer, Prostate Cancer, Health Equity, Disparities
Related terms Breast Neoplasms, Prostatic Neoplasms
Enrollment 1,116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov